Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions.

Founded in 1668, Merck is the world’s oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, Millipore Sigma and EMD Performance Materials.

www.merck.ae 

Sanofi is proud to support your vital mission. We share a commitment to advancing diabetes care for the people of Oman, offering a diverse portfolio designed to meet the varying needs of a large patient sector.

Our offerings provide healthcare professionals with flexible and effective therapeutic options to help patients achieve optimum glycemic control. This includes our long-standing basal insulin analogs, which offer proven efficacy and safety, and modern insulin solutions designed to simplify management. We are also dedicated to advancing treatment paradigms with innovative combinations and GLP-1 receptor agonists, supporting both glucose control and cardiovascular risk reduction.

By providing these trusted solutions, we aim to empower patients, improve adherence, and foster better long-term outcomes. We are committed to being your reliable partner in building a healthier future for those living with diabetes in Oman.

https://www.sanofi.com

Amgen is one of the world’s leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses.

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Our belief—and the core of our strategy—is that innovative, highly differentiated medicines that provide large clinical benefits in addressing serious diseases are medicines that will not only help patients, but also will help reduce the social and economic burden of disease in society today.

Servier is a global pharmaceutical group governed by a nonprofit foundation, committed to making a social impact for patients and contributing to a sustainable world. The Group’s unique governance model ensures its independence while fostering long-term innovation, with 100% of its profits reinvested in the company’s development. As a world leader in cardiometabolism and venous diseases, Servier drives transformative innovation in chronic conditions through a holistic approach, making patient adherence a priority across the globe. Its ambition is to become a leading player in rare cancers, which is why the Group invests heavily in oncology, allocating close to 70% of its R&D budget to this field.

Servier has expanded into neurology, a key driver of future growth. The Group focuses on a select number of neurodegenerative diseases. Headquartered in France, Servier operates in close to 140 countries. In 2023-2024, the Group, which employs over 22,000 people worldwide, achieved sales revenue of €5.9 billion.

https://servier-me.com/en/

At Ipsen, we’re dedicated to improving people’s lives and health outcomes. Our 5,000 employees around the world are committed to tackling areas of high unmet medical need to improve the quality of life of patients and caregivers.

www.ipsen.com

Daleel Petroleum is a leading exploration and production company operating in Oman's energy sector. Since our establishment in 2002, we have built a strong reputation through our commitment to operational excellence, technical expertise, and sustainable development of Oman's energy resources.

We strive to maximize production while maintaining the highest standards of safety and environmental protection. Our experienced team of Omani professionals combines local knowledge with cutting-edge technology to overcome the unique challenges of Oman's oilfields. Through strategic partnerships and continuous investment in our people and assets, we have consistently delivered value while upholding our social and environmental responsibilities.

Daleel Petroleum remains dedicated to responsible energy production that supports both current needs and future generations. We understand our role as stewards of Oman's natural resources and maintain this responsibility at the core of our operations. By implementing innovative solutions and best practices across our Block 5 concession area, we demonstrate our commitment to sustainable operations. Our focus remains on delivering reliable energy today while preparing for tomorrow's challenges.

https://daleelpetroleum.com/

الشركة العمانية للغاز الطبيعي المسال ش.م.م شركة محدودة المسؤولية تأسست بموجب مرسوم سلطاني سام صدر في عام 1994، ويتركز نشاطها في عمليات إسالة وبيع الغاز الطبيعي ومشتقاته من مكثفات الغاز، حيث تقوم الشركة بكافة المشاريع والعمليات والأنشطة اللازمة لإسالة الغاز الطبيعي وتخزينه وتسويقه فضلاً عن تصديره إلى العملاء. وتساهم أنشطة الشركة في أهداف الحكومة في تنويع مصادر الدخل. تدير الشركة في مجمعها الصناعي بصور ثلاث قاطرات لإسالة الغاز الطبيعي تبلغ طاقاتها الإنتاجية المحسنة 11.4 مليون طن متري بالسنة. وفي الأول من سبتمبر من عام 2013، دخلت صناعة الغاز حقبة جديدة مع اندماج الشركة العمانية للغاز الطبيعي المسال وقلهات للغاز الطبيعي المسال ليصبحا كياناً متكاملاً تحت مسمى الشركة العمانية للغاز الطبيعي المسال.

Oman Liquefied Natural Gas LLC (Oman LNG) is a Joint Venture established by a Royal Decree in 1994 and operates under the laws of the Sultanate of Oman. The Company engages in the business of producing and selling liquified natural gas (LNG), and its by-product, natural gas liquids (NGL). It undertakes project operations and activities essential to liquefy, store, transport, and market Oman's natural gas and deliver LNG to customers. The company's activities contribute to the government's objective of diversifying the economy. The company operates three liquefaction trains—two owned by Oman LNG LLC and one by Qalhat LNG SOAC with a nameplate capacity of 11.4 million metric tonnes per annum (mtpa)—at its plant in Qalhat, South Sharqiyah Governorates. On September 1st, 2013, Oman LNG and Qalhat LNG were integrated to form a single entity operating under the name of Oman LNG.

https://omanlng.co.om

A’Sharqiya Investment Holding Co. SAOG (SIHC) was promoted in 1998 mainly by a wide section of investors hailing from the A’ Sharqiya region with a mission for the development of the region and the country at large through promotion of projects of regional and national importance. The company was promoted with a paid-up capital of RO 6 million of which 40% was floated to the public during the ipo. The current paid-up capital of the company stands at RO 9 million. The company’s shares are listed and traded on the Muscat Securities Market.

https://asharqiya.com/